Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 110

    1.

    Priming With Angiopoietin-1 Augments the Vasculogenic Potential of the Peripheral Blood Stem Cells Mobilized With Granulocyte Colony-Stimulating Factor Through a Novel Tie2/Ets-1 Pathway.

    Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, Kang HJ, Lee DS, Koh GY, Nakagami H, Morishita R, Park YB, Kim HS.

    Circulation. 2009 Nov 16. [Epub ahead of print]PMID: 19917886 [PubMed - as supplied by publisher]Related articles

    2.

    Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.

    Tajiri S, Kanamaru T, Makoto K, Konno T, Nakagami H.

    Int J Pharm. 2010 Jan 4;383(1-2):99-105. Epub 2009 Sep 10.PMID: 19747964 [PubMed - in process]Related articles

    3.

    Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR.

    Ito A, Watanabe T, Yada S, Hamaura T, Nakagami H, Higashi K, Moribe K, Yamamoto K.

    Int J Pharm. 2010 Jan 4;383(1-2):18-23. Epub 2009 Sep 2.PMID: 19732816 [PubMed - in process]Related articles

    4.

    [Gene therapy for anti-aging medicine]

    Nakagami H, Morishita R.

    Nippon Rinsho. 2009 Jul;67(7):1407-11. Review. Japanese. PMID: 19591294 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats.

    Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, Yoshikawa H, Rakugi H, Ogihara T, Morishita R.

    Hypertens Res. 2009 Sep;32(9):786-90. Epub 2009 Jul 10.PMID: 19590507 [PubMed - in process]Related articles

    6.

    [Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism]

    Nakagami H, Morishita R.

    Clin Calcium. 2009 Jul;19(7):997-1002. Review. Japanese. PMID: 19567997 [PubMed - indexed for MEDLINE]Related articles

    7.

    Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis.

    Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, Koriyama H, Hayashi H, Sabe H, Mochizuki N, Morishita R, Kaneda Y.

    Mol Biol Cell. 2009 Jul;20(13):3115-24. Epub 2009 May 13.PMID: 19439447 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action.

    Hanayama R, Shimizu H, Nakagami H, Osako MK, Makino H, Kunugiza Y, Tomita T, Tsukamoto I, Yoshikawa H, Rakugi H, Morishita R.

    Int J Mol Med. 2009 May;23(5):581-8.PMID: 19360315 [PubMed - indexed for MEDLINE]Related articles

    9.

    FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.

    Hayashi H, Nakagami H, Takami Y, Koriyama H, Mori M, Tamai K, Sun J, Nagao K, Morishita R, Kaneda Y.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):909-14. Epub 2009 Mar 26.PMID: 19325137 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway.

    Aoki T, Kataoka H, Ishibashi R, Nakagami H, Nozaki K, Morishita R, Hashimoto N.

    Neurosurgery. 2009 Feb;64(2):357-65; discussion 365-6.PMID: 19190463 [PubMed - indexed for MEDLINE]Related articles

    11.

    New Treatment of Periodontal Diseases Using NFkB Decoy Oligodeoxunuclotides via Prevention of Bone Resorption and Promotion of Wound Healing.

    Shimizu H, Nakagami H, Morita S, Tsukamoto I, Osako MK, Nakagami F, Shimosato T, Minobe N, Morishita R.

    Antioxid Redox Signal. 2009 Feb 1. [Epub ahead of print]PMID: 19186992 [PubMed - as supplied by publisher]Related articles

    12.

    Vascular protective effects of ezetimibe in ApoE-deficient mice.

    Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R.

    Atherosclerosis. 2009 Mar;203(1):51-8. Epub 2008 May 27.PMID: 18603252 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evaluation of solid dispersions on a molecular level by the Raman mapping technique.

    Furuyama N, Hasegawa S, Hamaura T, Yada S, Nakagami H, Yonemochi E, Terada K.

    Int J Pharm. 2008 Sep 1;361(1-2):12-8. Epub 2008 May 16.PMID: 18584979 [PubMed - indexed for MEDLINE]Related articles

    14.

    Development of a method for the determination of caffeine anhydrate in various designed intact tablets [correction of tables] by near-infrared spectroscopy: a comparison between reflectance and transmittance technique.

    Ito M, Suzuki T, Yada S, Kusai A, Nakagami H, Yonemochi E, Terada K.

    J Pharm Biomed Anal. 2008 Aug 5;47(4-5):819-27. Epub 2008 Apr 10.PMID: 18508223 [PubMed - indexed for MEDLINE]Related articles

    15.

    Large-scale phosphorylation mapping reveals the extent of tyrosine phosphorylation in Arabidopsis.

    Sugiyama N, Nakagami H, Mochida K, Daudi A, Tomita M, Shirasu K, Ishihama Y.

    Mol Syst Biol. 2008;4:193. Epub 2008 May 6.PMID: 18463617 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.

    Nishikawa T, Nakagami H, Maeda A, Morishita R, Miyazaki N, Ogawa T, Tabata Y, Kikuchi Y, Hayashi H, Tatsu Y, Yumoto N, Tamai K, Tomono K, Kaneda Y.

    J Cell Mol Med. 2009 Mar;13(3):535-46. Epub 2008 Apr 9.PMID: 18410525 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol.

    Kuno Y, Kojima M, Nakagami H, Yonemochi E, Terada K.

    Eur J Pharm Biopharm. 2008 Aug;69(3):986-92. Epub 2008 Feb 23.PMID: 18396020 [PubMed - indexed for MEDLINE]Related articles

    18.

    Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension.

    Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S, Rakugi H, Kaneda Y, Shimamoto K, Ogihara T.

    Hypertens Res. 2007 Dec;30(12):1239-46.PMID: 18344630 [PubMed - indexed for MEDLINE]Related articles

    19.

    Angiotensin II accelerates osteoporosis by activating osteoclasts.

    Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R.

    FASEB J. 2008 Jul;22(7):2465-75. Epub 2008 Feb 6.PMID: 18256306 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.

    Takami Y, Nakagami H, Morishita R, Katsuya T, Hayashi H, Mori M, Koriyama H, Baba Y, Yasuda O, Rakugi H, Ogihara T, Kaneda Y.

    Am J Pathol. 2008 Mar;172(3):818-29. Epub 2008 Feb 2.PMID: 18245814 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.

    Nakagami H, Kaneda Y, Ogihara T, Morishita R.

    Curr Diabetes Rev. 2005 Feb;1(1):59-63. Review.PMID: 18220582 [PubMed - indexed for MEDLINE]Related articles

    22.

    Effect of preparation method on properties of orally disintegrating tablets made by phase transition.

    Kuno Y, Kojima M, Ando S, Nakagami H.

    Int J Pharm. 2008 May 1;355(1-2):87-92. Epub 2007 Dec 4.PMID: 18182258 [PubMed - indexed for MEDLINE]Related articles

    23.

    NF-kappaB is a key mediator of cerebral aneurysm formation.

    Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T, Ishibashi R, Nozaki K, Morishita R, Hashimoto N.

    Circulation. 2007 Dec 11;116(24):2830-40. Epub 2007 Nov 19.PMID: 18025535 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Trojan horse strategy in Agrobacterium transformation: abusing MAPK defense signaling.

    Djamei A, Pitzschke A, Nakagami H, Rajh I, Hirt H.

    Science. 2007 Oct 19;318(5849):453-6.PMID: 17947581 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element.

    Saito Y, Nakagami H, Kurooka M, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Morishita R, Azuma N, Sasajima T, Kaneda Y.

    Oncogene. 2008 Mar 20;27(13):1821-33. Epub 2007 Oct 15.PMID: 17934523 [PubMed - indexed for MEDLINE]Related articles

    26.

    Involvement of gamma-secretase in postnatal angiogenesis.

    Hayashi H, Nakagami H, Takami Y, Sato N, Saito Y, Nishikawa T, Mori M, Koriyama H, Tamai K, Morishita R, Kaneda Y.

    Biochem Biophys Res Commun. 2007 Nov 23;363(3):584-90. Epub 2007 Sep 14.PMID: 17888873 [PubMed - indexed for MEDLINE]Related articles

    27.

    Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.

    Takami Y, Nakagami H, Morishita R, Katsuya T, Cui TX, Ichikawa T, Saito Y, Hayashi H, Kikuchi Y, Nishikawa T, Baba Y, Yasuda O, Rakugi H, Ogihara T, Kaneda Y.

    Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2184-90. Epub 2007 Aug 9.PMID: 17690318 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus.

    Osako MK, Tomita N, Nakagami H, Kunugiza Y, Yoshino M, Yuyama K, Tomita T, Yoshikawa H, Ogihara T, Morishita R.

    J Gene Med. 2007 Sep;9(9):812-9.PMID: 17640082 [PubMed - indexed for MEDLINE]Related articles

    29.

    Novel drug delivery system by surface modified magnetic nanoparticles.

    Takeda S, Terazono B, Mishima F, Nakagami H, Nishijima S, Kaneda Y.

    J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3269-76.PMID: 17048546 [PubMed - indexed for MEDLINE]Related articles

    30.

    A Mitogen-activated protein kinase kinase kinase mediates reactive oxygen species homeostasis in Arabidopsis.

    Nakagami H, Soukupová H, Schikora A, Zárský V, Hirt H.

    J Biol Chem. 2006 Dec 15;281(50):38697-704. Epub 2006 Oct 16.PMID: 17043356 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.

    Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, Kaneda Y.

    Circulation. 2006 Sep 12;114(11):1177-84. Epub 2006 Sep 4.PMID: 16952986 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    [Endothelial cell growth inhibitory gene]

    Nakagami H, Kaneda T.

    Nippon Rinsho. 2006 Jul;64 Suppl 5:428-31. Review. Japanese. No abstract available. PMID: 16895210 [PubMed - indexed for MEDLINE]Related articles

    33.

    Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine.

    Nakagami H, Nakagawa N, Takeya Y, Kashiwagi K, Ishida C, Hayashi S, Aoki M, Matsumoto K, Nakamura T, Ogihara T, Morishita R.

    Hypertension. 2006 Jul;48(1):112-9. Epub 2006 Jun 5.PMID: 16754788 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy.

    Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y.

    J Atheroscler Thromb. 2006 Apr;13(2):77-81. Review.PMID: 16733294 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.

    Nakagami H, Tomita N, Kaneda Y, Ogihara T, Morishita R.

    Curr Pharm Biotechnol. 2006 Apr;7(2):95-100. Review.PMID: 16724943 [PubMed - indexed for MEDLINE]Related articles

    36.

    Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector.

    Nishikawa T, Nakagami H, Matsuki A, Maeda A, Yo CY, Harada T, Morishita R, Tamai K, Kaneda Y.

    Hum Gene Ther. 2006 Apr;17(4):470-5.PMID: 16610935 [PubMed - indexed for MEDLINE]Related articles

    37.

    Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.

    Xiang F, Sakata Y, Cui L, Youngblood JM, Nakagami H, Liao JK, Liao R, Chin MT.

    Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1997-2006.PMID: 16603706 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.

    Shimizu H, Nakagami H, Tsukamoto I, Morita S, Kunugiza Y, Tomita T, Yoshikawa H, Kaneda Y, Ogihara T, Morishita R.

    Gene Ther. 2006 Jun;13(12):933-41. Epub 2006 Mar 2.PMID: 16511526 [PubMed - indexed for MEDLINE]Related articles

    39.

    The membrane-anchored BOTRYTIS-INDUCED KINASE1 plays distinct roles in Arabidopsis resistance to necrotrophic and biotrophic pathogens.

    Veronese P, Nakagami H, Bluhm B, Abuqamar S, Chen X, Salmeron J, Dietrich RA, Hirt H, Mengiste T.

    Plant Cell. 2006 Jan;18(1):257-73. Epub 2005 Dec 9.PMID: 16339855 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.

    Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y.

    Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2542-7. Epub 2005 Oct 13.PMID: 16224047 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector.

    Morishita N, Nakagami H, Morishita R, Takeda S, Mishima F, Terazono B, Nishijima S, Kaneda Y, Tanaka N.

    Biochem Biophys Res Commun. 2005 Sep 9;334(4):1121-6.PMID: 16134237 [PubMed - indexed for MEDLINE]Related articles

    42.

    Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue.

    Imai Y, Ishikawa T, Tanikawa T, Nakagami H, Maekawa T, Kurohane K.

    J Immunol Methods. 2005 Jul;302(1-2):125-35.PMID: 15992815 [PubMed - indexed for MEDLINE]Related articles

    43.

    Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.

    Kuno Y, Kojima M, Ando S, Nakagami H.

    J Control Release. 2005 Jun 20;105(1-2):16-22.PMID: 15955365 [PubMed - indexed for MEDLINE]Related articles

    44.

    Emerging MAP kinase pathways in plant stress signalling.

    Nakagami H, Pitzschke A, Hirt H.

    Trends Plant Sci. 2005 Jul;10(7):339-46.PMID: 15953753 [PubMed - indexed for MEDLINE]Related articles

    45.

    Hepatocyte growth factor as potential cardiovascular therapy.

    Nakagami H, Kaneda Y, Ogihara T, Morishita R.

    Expert Rev Cardiovasc Ther. 2005 May;3(3):513-9. Review.PMID: 15889978 [PubMed - indexed for MEDLINE]Related articles

    46.

    Heavy metal stress. Activation of distinct mitogen-activated protein kinase pathways by copper and cadmium.

    Jonak C, Nakagami H, Hirt H.

    Plant Physiol. 2004 Oct;136(2):3276-83. Epub 2004 Sep 24.PMID: 15448198 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: role of Bcl-2, Bcl-xL and Bax in tubular injury.

    Yamamoto K, Tomita N, Yoshimura S, Nakagami H, Taniyama Y, Yamasaki K, Ogihara T, Morishita R.

    Int J Mol Med. 2004 Oct;14(4):633-40.PMID: 15375594 [PubMed - indexed for MEDLINE]Related articles

    48.

    Statins and myocardial hypertrophy.

    Nakagami H, Liao JK.

    Coron Artery Dis. 2004 Aug;15(5):247-50. Review.PMID: 15238820 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells.

    Nakagami H, Morishita R, Nishikawa T, Shimizu H, Iguchi S, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.

    Hypertens Res. 2004 May;27(5):359-65.PMID: 15198484 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    OMTK1, a novel MAPKKK, channels oxidative stress signaling through direct MAPK interaction.

    Nakagami H, Kiegerl S, Hirt H.

    J Biol Chem. 2004 Jun 25;279(26):26959-66. Epub 2004 Mar 19.PMID: 15033984 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...